EMICRO Biomedicine at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

EMICRO Biomedicine at BIO-Europe 2026 in Cologne: 1 session (1 talk).

OrganizationBIO-Europe 2026 Attendance
EMICRO Biomedicine
Xinxiang, China
Biotech
Develops anti-cancer drugs, active pharmaceutical ingredients and formulations, and has a BTK inhibitor for multiple sclerosis in phase I.
Talk
Mon Nov 9
09:45–10:00
Autoimmune/Inflammation: Henan EMICRO Biomedicine Co., Ltd.
A pipeline of first-in-class drugs for autoimmune diseases and cancer, mixing proven pathways with new targets across clinical and preclinical stages.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from EMICRO Biomedicine

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction